Expanded ATXN1 alters transcription and calcium signaling in SCA1 human motor neurons differentiated from induced pluripotent stem cells

Neurobiol Dis. 2024 Oct 15:201:106673. doi: 10.1016/j.nbd.2024.106673. Epub 2024 Sep 20.

Abstract

Spinocerebellar ataxia type 1 (SCA1) is a dominantly inherited and lethal neurodegenerative disease caused by the abnormal expansion of CAG repeats in the ATAXIN-1 (ATXN1) gene. Pathological studies identified dysfunction and loss of motor neurons (MNs) in the brain stem and spinal cord, which are thought to contribute to premature lethality by affecting the swallowing and breathing of SCA1 patients. However, the molecular and cellular mechanisms of MN pathogenesis remain unknown. To study SCA1 pathogenesis in human MNs, we differentiated induced pluripotent stem cells (iPSCs) derived from SCA1 patients and their unaffected siblings into MNs. We examined proliferation of progenitor cells, neurite outgrowth, spontaneous and glutamate-induced calcium activity of SCA1 MNs to investigate cellular mechanisms of pathogenesis. RNA sequencing was then used to identify transcriptional alterations in iPSC-derived MN progenitors (pMNs) and MNs which could underlie functional changes in SCA1 MNs. We found significantly decreased spontaneous and evoked calcium activity and identified dysregulation of genes regulating calcium signaling in SCA1 MNs. These results indicate that expanded ATXN1 causes dysfunctional calcium signaling in human MNs.

Keywords: Calcium signaling; Motor neurons; SCA1; Transcription; iPSCs.

MeSH terms

  • Ataxin-1* / genetics
  • Ataxin-1* / metabolism
  • Calcium Signaling* / physiology
  • Cell Differentiation* / physiology
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Motor Neurons* / metabolism
  • Spinocerebellar Ataxias* / genetics
  • Spinocerebellar Ataxias* / metabolism
  • Spinocerebellar Ataxias* / pathology
  • Transcription, Genetic / physiology

Substances

  • Ataxin-1
  • ATXN1 protein, human